Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

COLUMBIA ADVANCED SCIENCE LC

UEI: CYMUANDQB5X5

COLUMBIA ADVANCED SCIENCE LC is a federal contractor, registered under UEI CYMUANDQB5X5. It has been awarded $25,000 across 1 federal contract. Primary work spans Medicinal and Botanical Manufacturing. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

CYMUANDQB5X5

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$25.0K100%

Awards by NAICS

325411 - Medicinal and Botanical Manufacturing$25.0K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in COLUMBIA ADVANCED SCIENCE LC's top NAICS codes and agencies

NIRMATRELVIR AND RI

Solicitation # SPE2DP-26-T-4498

The contract specifies the procurement of 50 boxes of PAXLOVID, each containing 10 blister cards with three tablets each—two 150 mg nirmatrelvir tablets and one 100 mg ritonavir tablet—providing a five-day course of treatment with two daily doses per box. The product is manufactured by Pfizer Inc under part number NDC00069-5321-30 and is regulated by the FDA, requiring confirmation via EBS referral. Each box constitutes a complete unit of issue, and the medication must be shipped within 20 days to the delivery point in Williamsburg, Virginia, with no variance allowed in quantity. The shelf life is fixed at 36 months and non-extendable, with packaging required to meet MIL-STD-2073-1E standards and medical marking Standard No. 1, superseding MIL-STD-129. All shipments must be traceable, cannot use parcel post, and must comply with DLA packaging and marking requirements. The contract is issued under solicitation SPE2DP-26-T-4498 with a response deadline of August 11, 2026, and an original required delivery date of April 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

CALCIUM CHLORIDE INJEC

Solicitation # SPE2DP-26-T-4471

CALCIUM CHLORIDE INJECTION USP is procured as a 10 mL single-dose plastic syringe containing 1 gram of calcium chloride (100 mg/mL), packaged ten syringes per unit (1 PG = 10 EA), with a mandatory 24-month shelf life from the date of manufacture, no less than 21 months of which must remain at the time of delivery to the government. The product must be labeled in strict accordance with Medical Marking Standard No. 1, including the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, contract number, and lot number, and stored at 20 to 25°C (68 to 77°F). The item is regulated by the FDA and requires prior confirmation from the product specialist via EBS referral before award. Packaging must be commercial and designed to protect against damage, with exterior shipping containers ensuring safe, cost-effective transport to the delivery point. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The manufacturer is Pfizer Inc, with NDC 00409-1631-10, and the item is identified by NSN 6505-01-655-0700. Delivery is FOB destination in 20 days to Fort Campbell, Kentucky, with zero quantity variance permitted, and shipment must occur via traceable means, excluding parcel post. The contract reference is SPE2DP-26-T-4471, with an original required delivery date of August 5, 2026, and procurement governed by the DLA Master List of Technical and Quality Requirements, which take precedence over all other standards including ASTM D3951.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANALGESIC GEL, TOPICAL

Solicitation # SPE2DP-26-T-4491

The contract solicits a topical analgesic gel containing 5% menthol USP, packaged in 4 oz tubes with 144 tubes per case, designated by NSN 6505-01-658-7643. The product is classified as flammable and must be stored at 20–25°C (68–77°F). It carries a non-extendable shelf life of 24 months and is subject to specific packaging standards under Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed in protective containers and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate, with all markings compliant with medical logistics requirements. Hazard communication regulations under OSHA’s revised HCS and 29 C.F.R. 1910.1200 apply, requiring suppliers to submit approved Safety Data Sheets and compliant labels to the contracting officer before award. A current SDS must accompany each shipment and be submitted electronically to DLA.MSDS@DLA.MIL with the required cover sheet. The product must comply with 49 CFR and ICAO regulations for hazardous materials, and suppliers must train employees on these requirements. The solicitation, issued under SPE2DP-26-T-4491, has a response deadline of August 10, 2026, with delivery to Fort Campbell, Tennessee, required within 20 days of award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATE

Solicitation # SPE2DP-26-T-4473

Sumatriptan Succinate Tablets, 100mg, are supplied in bottles of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at 20 to 25°C (68 to 77°F) and protected from light, complying with USP controlled room temperature standards. It is subject to a non-extendable 24-month shelf life under Type I (Code M) requirements, with packaging and marking mandated to adhere to MIL-STD-2073-1E and MIL-STD-129, as well as the latest Medical Marking Standard No. 1. The supply is regulated by the FDA, and contractors must provide detailed manufacturer and product information for official verification. Two line items total two bottles, with delivery required within five days to two separate military addresses: one at Joint Base Elmendorf-Richardson, Alaska, and the other at Ramstein Air Base, Germany. Both shipments are FOB destination, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The contract includes DLA-specific packaging, procurement, and logistics requirements, referencing technical standards from the DLA Master List, and is issued under solicitation SPE2DP-26-T-4473 with a required delivery date of August 5–6, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DDDPlus Software Licensing and SupportThe contract entails the provision of five individual Standard licenses for DDDPlus software, covering full delivery, installation, and compatibility testing to ensure seamless integration with existing systems. License administration will be maintained throughout a four-year term, including ongoing support and compliance management. The work is performance-based with the place of performance located in Silver Spring, Maryland, under a subcontract structure, and falls under the NAICS code 511210 for software publishing. The Department of Health and Human Services is the contracting organization, with a response deadline set for August 14, 2026, and the solicitation was posted on August 4, 2026. All activities must align with federal procurement standards and deliverables must meet technical and operational requirements specified in the agreement.

Department Of Health And Human Services

POSTED

DEADLINE

GastroPlus Software Licensing and SupportThe contract awards the supply and ongoing support of 20 Standard licenses for GastroPlus software over a four-year period, encompassing full delivery, installation, and verification of compatibility with FDA systems. The provider is responsible for ensuring seamless integration into existing infrastructure and managing all aspects of license administration throughout the term. Performance is required to occur at the designated location in Silver Spring, Maryland, with the work falling under NAICS code 511210 for software publishing. The opportunity was posted on August 4, 2026, and responses are due by August 14, 2026, with the contracting entity being the Department of Health and Human Services. This subcontract supports critical regulatory and scientific operations that rely on GastroPlus for pharmacokinetic and pharmacodynamic modeling within federal health and safety contexts.

Department Of Health And Human Services

POSTED

DEADLINE

Notice of Sole Source: GastroPlus PBPK and PBBM modeling platform subscription

Solicitation # 7571TE26Q00153

The U.S. Food and Drug Administration, through the Department of Health and Human Services, intends to sole-source a firm fixed-price contract to Simulations Plus Inc. for twenty GastroPlus and five DDDPlus software licenses, used for physiologically based pharmacokinetic and physiologically based biopharmaceutics modeling in support of generic drug research. The contract spans a base year from September 1, 2026, to August 31, 2027, with up to three one-year option periods extending through August 31, 2030. Performance will occur at the FDA’s White Oak campus in Silver Spring, Maryland. The acquisition is conducted under RFO 12, allowing for non-competitive procurement of commercial products, and no set-aside applies. Responses are due by August 14, 2026, and any interested party may submit a capability statement to demonstrate their ability to supply the exact software licenses as the original equipment manufacturer or authorized reseller, which the government will review solely to determine whether competitive procurement is warranted. The contract requires the vendor to provide standard individual licenses, with no auto-renewals permitted unless explicitly authorized. Acceptance of deliverables will be conducted by the Contracting Officer’s Representative within 30 working days of delivery, verifying software functionality, compatibility with FDA systems, and compliance with technical requirements. Invoicing must be submitted electronically through the Treasury’s Invoice Processing Platform, and all invoices must include detailed supporting documentation for labor, materials, and costs. The government retains the right to reject nonconforming deliveries and will not pay for services that fail to meet agreed standards. Clauses from the FAR and HHSAR govern payment, representation, whistleblower rights, anti-lobbying, accessibility, and dispute resolution, with federal regulations taking precedence over any vendor terms. The Contracting Officer and Contract Specialist are the primary points of contact, and all vendors must be actively registered in SAM at the time of submission.

Department Of Health And Human Services

POSTED

DEADLINE

MAGNESIUM SULFATE

Solicitation # SPE2DP-26-T-4456

MAGNESIUM SULFATE 495MG/5GM oral granules in 454GM bags, sold in cases of 12 bags each, is procured under contract SPE2DP-26-T-4456 for delivery to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632 with a five-day delivery window and no tolerance for quantity variance. The product is classified as a TYPE I (CODE Q) medical item with a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. All packaging must meet commercial standards as specified in DLA’s procurement requirements, ensuring each unit is sealed in protective containers and packed in exterior shipping containers suitable for safe, low-cost transport by common carrier to the destination. Palletization and labeling must adhere to DLA’s Packaging Requirements for Procurement and the latest version of Medical Marking Standard No. 1, available through DLA Troop Support or their official website. The item is identified by NSN 6505-01-714-4975 and NDC 46122-0461-43, supplied by AMERISOURCEBERGEN DRUG CORP, and shipped via traceable methods only—parcel post is prohibited. Delivery is FOB destination with inspection and acceptance also occurring at the point of delivery, and the required delivery date is August 5, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Unable to Decompose Subcontract OpportunitiesDue to a system error, the prime contract details necessary to identify or structure subcontract opportunities could not be retrieved, rendering all subcontracting analysis unavailable at this time. The solicitation is designated as a subcontract under the Department of Health and Human Services, with a posted date of August 3, 2026, and a response deadline of August 18, 2026. The place of performance is listed as Bethesda, Maryland, with a zip code of 20892, though no specific office address, point of contact, or set-aside information is provided. The NAICS code is marked as NA, and the agency and organizational designations are identical, indicating an internal system limitation. Despite the absence of actionable data for suppliers, the opportunity remains live in the system with a public view link available for reference.

Department Of Health And Human Services

POSTED

DEADLINE

Antioxidant Therapy for Smith-Lemli-Opitz Syndrone

Solicitation # NICHD-08610

The contract pertains to the development and implementation of antioxidant therapy for Smith-Lemli-Opitz Syndrome, a rare genetic disorder characterized by multiple congenital anomalies and metabolic dysfunction. The solicitation, issued under NICHD-08610 by the Department of Health and Human Services through its National Institutes of Health, invites proposals aimed at advancing targeted antioxidant interventions to mitigate the pathological effects of the condition. The opportunity was posted on August 3, 2026, with responses due by August 18, 2026, at 2:00 PM Eastern Time. The work is expected to be performed in Bethesda, Maryland, consistent with the research infrastructure of the NIH campus. All proposals must be submitted through the SAM.gov portal and should address scientific rigor, feasibility, and potential clinical impact. The primary point of contact for inquiries is Niamh Cawley, with Chung Huang as the secondary contact, both reachable via NIH email addresses. The contracting activity falls under the Department of Health and Human Services with no set-aside provisions specified, and no NAICS code is assigned, indicating flexibility in contractor categorization. Interested parties should ensure adherence to deadlines and submission requirements outlined on the official UI link linked in the posting.

Department Of Health And Human Services

POSTED

DEADLINE

Manufacturing of CARD Casualty Response Documentation ToolThe contract is for the full production of a durable, field-ready medical documentation card designed to support casualty response operations, adhering strictly to the DLA Master List technical and quality standards. The product must be robust enough for frontline use under demanding conditions and capable of reliably conveying critical medical information in austere environments. Production will be executed as a subcontract under the Department of Defense’s Medical Supply Chain MD Surg FSF, with the place of performance located in WaterVliet, New York, at the ZIP code 12189-5000. The NAICS code 325411 indicates the work falls under pharmaceutical and medicine manufacturing, underscoring the precision and regulatory compliance required in materials and processes. The solicitation was posted on August 2, 2026, with a response deadline of August 10, 2026, allowing potential subcontractors a limited window to submit proposals. The contract type is explicitly labeled as a subcontract, meaning the winning party will be engaged by a prime contractor rather than directly by the government. There is no set-aside classification specified, indicating the opportunity is open to all eligible entities regardless of business size or status. While no point of contact is listed, interested parties can access additional details through the provided DIBBS link, which hosts the official request for quotation. The focus is squarely on delivering a standardized, high-integrity medical documentation tool that meets rigorous military specifications for reliability and performance.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Hydrocortisone Cream 2.5% (NSN 6505017157536)The contract entails the procurement and delivery of ten units of Hydrocortisone Cream 2.5% in one-ounce tubes, specifically designated by NSN 6505017157536, ensuring full compliance with FDA regulations and adherence to Department of Defense medical and logistical standards as defined by DLA. All products must meet stringent military medical requirements for quality, packaging, labeling, and shelf life to support operational readiness and field distribution. The solicitation is issued under a subcontract mechanism with a NAICS code of 325411, indicating pharmaceutical manufacturing, and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. Responses are due by August 10, 2026, with the opportunity posted on August 2, 2026, providing suppliers eight days to submit proposals. The place of performance and point of contact details are not specified, but delivery must fulfill the logistical needs of the Defense Logistics Agency. The contract is accessible through the DIBBS platform, and while no set-aside designation is listed, all offerings must be FDA-approved and aligned with the prescribed military medical specifications for use in deployed and garrison medical facilities.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Omeprazole Extended-Release Capsules (NSN 6505016247068)The contract solicits suppliers to provide FDA-approved Omeprazole Extended-Release Capsules in bulk quantities that fully comply with National Stock Number NSN 6505016247068 specifications, ensuring eligibility for procurement by the Defense Logistics Agency. The product must meet all regulatory and quality standards required for use within U.S. military medical supply chains and is intended for distribution through the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. Submission deadlines are firm, with responses due by August 10, 2026, and the solicitation is structured as a subcontract under the NAICS code 325411, which pertains to pharmaceutical and biological product manufacturing. All deliveries are to be addressed to the designated place of performance in APO, ZIP 96264-2022, with no additional office address details provided. The contract is posted on the DIBBS platform and is open to qualified manufacturers capable of meeting stringent military pharmaceutical requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of NSN 6505-01-719-3181 Medical or Hazardous ItemThe contract requires the supply of a commercial item identified by NSN 6505-01-719-3181, which must meet all applicable medical, packaging, and hazardous material regulations. This item is intended for use within the Department of Defense’s medical supply chain and must be delivered in full compliance with federal standards for handling and transport of sensitive medical or hazardous goods. The work is to be performed at FPO with a ZIP code of 96675, and the contract is classified as a subcontract under NAICS code 325411, indicating the manufacturing of pharmaceutical and botanical products. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026, and the official interface for details can be accessed through the DLA Dibbs platform.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Sodium Chloride Injection and Medical ConsumablesThe contract seeks a supplier to provide FDA-regulated sodium chloride injection syringes and related medical consumables that comply with strict shelf-life and packaging standards required for military medical use. The items must meet regulatory and quality benchmarks to ensure safety, sterility, and operational readiness within Department of Defense healthcare systems. Performance is scheduled to be fulfilled at the WaterVliet location with zip code 12189-5000, indicating the physical delivery point for these critical medical supplies. This is a subcontract opportunity issued under the NAICS code 325411 for pharmaceutical manufacturing and was posted on August 2, 2026, with responses due by August 10, 2026. It is managed by the Medical Supply Chain Pharm FSA under the Department of Defense and is part of the broader effort to maintain reliable, high-integrity medical inventory for U.S. military operations. Suppliers must adhere to all federal medical device and pharmaceutical regulations and deliver fully compliant products to support the readiness of deployed medical teams.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PSYLLIUM HYDROPHILIC M

Solicitation # SPE2DP-26-T-4405

The contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12-gram packets, each containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per case. This product is regulated by the FDA and must be supplied with its manufacturer’s part number NDC37000-0740-87, sourced from Procter & Gamble Distributing LLC. The item has a non-extendable shelf life of 24 months and must comply with DLA’s technical and quality requirements as defined in the DLA Master List, with packaging and marking strictly governed by Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet MIL-STD-2073-1E and DLA-specific packaging requirements, ensuring secure, commercial-grade containment capable of protecting contents during transit. Delivery is FOB destination with no tolerance for quantity variance, and items must be shipped within five days of contract award using the fastest traceable means—parcel post is prohibited. The delivery address is a Navy vessel in FPO AP 96675, with specific shipping and marking instructions governed by DLA’s logistics protocols. The NSN is 6505-01-719-3181, and the contract number is SPE2DP-26-T-4405, with an original required delivery date of August 4, 2026. All bids must include the supplier and manufacturer details for FDA referral through EBS prior to award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATE

Solicitation # SPE2DP-26-T-4415

Sumatriptan Succinate Tablets, 100 mg, are supplied in a bottle of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, in compliance with USP standards. The item is regulated by the FDA and subject to strict shelf-life requirements: it has a non-extendable shelf life of 24 months as a Type I CODE M item, and must be marked according to the latest edition of Medical Marking Standard No. 1 and MIL-STD-129 for packaging and labeling. Packaging and palletization must adhere to DLA’s Packaging Requirements for Procurement and MIL-STD-2073-1E, with no tolerance for quantity variance. The contract specifies delivery FOB destination within 20 days, with inspection and acceptance occurring at the destination. The supplier is identified as MYLAN PHARMACEUTICALS INC with NDC 00378-5632-59, and the item is procured under NSN 6505-01-727-8704. Delivery is to a U.S. military address in APO AE 09094-3219, with freight originating from Ramstein, Germany. The solicitation number is SPE2DP-26-T-4415, with a required delivery date of August 4, 2026, and bid responses due by August 10, 2026. Technical and quality requirements are governed by the DLA Master List, and the contracting official must submit a referral through EBS for FDA product validation prior to award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CARD CASUALTY RESPO

Solicitation # SPE2DS-26-T-298R

The CARD CASUALTY RESPONSE DOCUMENTATION TOOL is a compact, durable card measuring 6.5 inches by 4 and 2/8 inches, constructed from card stock with a grommet and sealed in clear plastic for protection, accompanied by a 14-inch cable tie to securely fasten it to the patient. Designed for frontline responders, it captures essential data elements required for initial casualty treatment documentation. Each card includes a unique individual bar code identifier to ensure accurate tracking and record linkage. The unit of issue is singular, and the item is designated by NSN 6515-01-575-2772 with a procurement quantity of 8 units under purchase request 7017710965. Delivery is required within five days of award, with performance occurring in WaterVliet, New York, 12189-5000. The contract, issued under solicitation SPE2DS-26-T-298R, is subject to technical and quality requirements from the DLA Master List, with compliance dependent on the revision in effect at the solicitation or award date. It falls under NAICS code 325411 and is managed by the Department of Defense’s Medical Supply Chain MD Surg FSF. The item is classified as potentially containing covered defense information, and packaging must follow DLA procurement standards. Government identification must be removed from non-accepted supplies, and bidders are required to specify their source and part number. All submissions must be made prior to the response deadline of August 10, 2026, with the solicitation posted on August 2, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE